Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
FDA Proposes Skin Reaction Label Warning for Tylenol, Other Drugs Containing Acetaminophen A wealth of scientific data has linked the use of acetaminophen to incidents of Stevens-Johnson Syndrome and other potentially dangerous allergic reactions June 21, 2024 Irvin Jackson Add Your Comments Federal drug regulators are calling for Tylenol and other acetaminophen-based drugs to carry warnings about the risk of dangerous skin reactions, following years of reports and scientific data linking the popular pain killer to the development of Stevens-Johnson Syndrome. The U.S. Food and Drug Administration (FDA) issued a proposed administrative order (PDF) on June 14, which would affect the over-the-counter labels on drugs containing acetaminophen. The proposed order would alert consumers to the risks of allergic skin reactions that could result in skin reddening, blisters, and rash. The warning comes after a long history of data linking acetaminophen to a devastating skin condition known as Stevens-Johnson Syndrome (SJS), which can result in painful blisters, severe rash and can cause the skin to separate from the body. When the skin lesions affect more than 30% of the body, the condition is typically referred to as toxic epidermal necrolysis (TEN), which often results in the need for treatment in a hospital Intensive Care Unit (ICU) or Burn Unit. Prior studies have linked the development of Stevens-Johnson syndrome to anticonvulsants, antibiotics and non-steroidal anti-inflammatory drugs (NSAIDS), but acetaminophen has always been one of the most widely cited causes. In 2014, the FDA issued a draft guidance calling for new label warnings for Tylenol and other acetaminophen drugs due to the risks of SJS and TEN. This proposed order would make that guidance a requirement. Tylenol Autism Lawsuit Does your child have Austism from Tylenol Exposure? Learn More SEE IF YOU QUALIFY FOR COMPENSATION Tylenol Autism Lawsuit Does your child have Austism from Tylenol Exposure? Learn More SEE IF YOU QUALIFY FOR COMPENSATION “Today’s actions represent important milestones in FDA’s implementation of new authorities provided by Congress as part of OTC Monograph Reform,” Dr. Theresa Michele, M.D., director of the Office of Nonprescription Drugs in FDA’s Center for Drug Evaluation and Research, said in a press release. “Today’s proposed order helps to ensure the safety and effectiveness of OTC drugs in our marketplace.” The warning would appear in the monograph of all over-the-counter drug products containing acetaminophen, including Tylenol. The FDA also released an acetaminophen scientific review (PDF), which lays out the agency’s reasoning for requiring the new label warnings. An updated review of reports submitted to the FDA identified 25 cases of SJS/TEN linked to acetaminophen use between February 2012 and June 2021. In addition, there were three reported cases of acute generalized exanthematous pustulosis (AGEP), which is a rare form of skin hypersensitivity adverse reaction, which can cause an outbreak of pustules on the skin, as well as fever. However, it is usually not life-threatening. The FDA is accepting public comment on the proposed acetaminophen label warning changes until July 29, 2024. Comments must be submitted electronically to https://dps.fda.gov/omuf with the proposed order ID number: OTC000035. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Acetaminophen, Skin Reactions, Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis, Tylenol More Tylenol Lawsuit Stories Study Finds Autism, ADHD Risks Linked to Prenatal Acetaminophen Use August 25, 2025 MDL Judge Grants Summary Judgment in All Tylenol Lawsuits Over Autism, ADHD August 21, 2024 Tylenol MDL Judge Rejects New Evidence That Prenatal Exposure to Acetaminophen Causes ADHD July 15, 2024 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Wayfair Fire Pit Lawsuit Links Flame Jetting Explosion to Defective Design (Posted: 2 days ago) In March 2026, a jury is scheduled to hear a Wayfair fire pit lawsuit from a woman who suffered burns to nearly half her body. MORE ABOUT: TABLETOP FIRE PIT LAWSUITAmazon Tabletop Fire Pit Lawsuit Alleges ‘Flame-Jetting’ Caused Third Degree Burns (08/29/2025)Tabletop Fire Pit Burn Victims Share Stories of Explosions and Devastating Injuries (08/21/2025)Colsen Fire Pit Lawsuit Involving Severe Burn Injuries Suffered by a Child Set for Trial Next Year (08/14/2025) Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (Posted: 3 days ago) Dupixent lawsuits are now being investigated after studies and FDA reports link Dupixent (dupilumab) to cutaneous T-cell lymphoma (CTCL). MORE ABOUT: DUPIXENT LAWSUITDupixent Side Effects May Increase Cutaneous T-Cell Lymphoma (CTCL) Risks (08/26/2025) Depo-Provera Meningioma Side Effects Significantly Increased Among Women Over 31: Study (Posted: 4 days ago) A new study appears to further confirm and quantify the risks of Depo-Provera meningioma side effects, potentially providing further evidence for growing litigation. MORE ABOUT: DEPO-PROVERA LAWSUITPfizer Seeks Dismissal of Depo-Provera Failure-To-Warn Lawsuits Over Meningioma Risks (09/02/2025)Nearly 1,000 Depo-Provera Meningioma Lawsuits Filed, With Another 9,500 Under Investigation (08/25/2025)Experts Weigh In On Depo-Provera Brain Tumor Risks, As Lawsuits Continue to Mount (08/20/2025)
Tylenol MDL Judge Rejects New Evidence That Prenatal Exposure to Acetaminophen Causes ADHD July 15, 2024
Wayfair Fire Pit Lawsuit Links Flame Jetting Explosion to Defective Design (Posted: 2 days ago) In March 2026, a jury is scheduled to hear a Wayfair fire pit lawsuit from a woman who suffered burns to nearly half her body. MORE ABOUT: TABLETOP FIRE PIT LAWSUITAmazon Tabletop Fire Pit Lawsuit Alleges ‘Flame-Jetting’ Caused Third Degree Burns (08/29/2025)Tabletop Fire Pit Burn Victims Share Stories of Explosions and Devastating Injuries (08/21/2025)Colsen Fire Pit Lawsuit Involving Severe Burn Injuries Suffered by a Child Set for Trial Next Year (08/14/2025)
Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (Posted: 3 days ago) Dupixent lawsuits are now being investigated after studies and FDA reports link Dupixent (dupilumab) to cutaneous T-cell lymphoma (CTCL). MORE ABOUT: DUPIXENT LAWSUITDupixent Side Effects May Increase Cutaneous T-Cell Lymphoma (CTCL) Risks (08/26/2025)
Depo-Provera Meningioma Side Effects Significantly Increased Among Women Over 31: Study (Posted: 4 days ago) A new study appears to further confirm and quantify the risks of Depo-Provera meningioma side effects, potentially providing further evidence for growing litigation. MORE ABOUT: DEPO-PROVERA LAWSUITPfizer Seeks Dismissal of Depo-Provera Failure-To-Warn Lawsuits Over Meningioma Risks (09/02/2025)Nearly 1,000 Depo-Provera Meningioma Lawsuits Filed, With Another 9,500 Under Investigation (08/25/2025)Experts Weigh In On Depo-Provera Brain Tumor Risks, As Lawsuits Continue to Mount (08/20/2025)